Cytokine regulation of tight junctions

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 4, 2009, Pages 864-871

  Capaldo, Christopher T ^a   Nusrat, Asma ^a  

^a Epithelial Pathobiology Research Unit   (United States)

Author keywords

Claudin; Cytokine; IFN gamma; Interleukin; Paracellular permiability; Tight junction; TNF alpha; ZO 1

Indexed keywords

ACTIN; CELL PROTEIN; CLAUDIN; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; OCCLUDIN; TUMOR NECROSIS FACTOR ALPHA;

ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TIGHT JUNCTION;

ACTINS; ANIMALS; CYTOKINES; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; MEMBRANE PROTEINS; TIGHT JUNCTIONS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63249123919     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.08.027     Document Type: Review

References (108)

1. Holgate S.T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120 (2007) 1233-1244 quiz 1245-6
2. Coyne C.B., Vanhook M.K., Gambling T.M., Carson J.L., Boucher R.C., and Johnson L.G. Regulation of airway tight junctions by proinflammatory cytokines. Mol. Biol. Cell 13 (2002) 3218-3234
3. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune. Pharmacol. 1 (2006) 223-236
4. Lui W.Y., and Cheng C.Y. Regulation of cell junction dynamics by cytokines in the testis: a molecular and biochemical perspective. Cytokine Growth Factor Rev. 18 (2007) 299-311
5. Khaled W.T., Read E.K., Nicholson S.E., Baxter F.O., Brennan A.J., Came P.J., Sprigg N., McKenzie A.N., and Watson C.J. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development 134 (2007) 2739-2750
6. Katz K.D., Hollander D., Vadheim C.M., McElree C., Delahunty T., Dadufalza V.D., Krugliak P., and Rotter J.I. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 97 (1989) 927-931
7. Peeters M., Geypens B., Claus D., Nevens H., Ghoos Y., Verbeke G., Baert F., Vermeire S., Vlietinck R., and Rutgeerts P. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 113 (1997) 802-807
8. Olson T.S., Reuter B.K., Scott K.G., Morris M.A., Wang X.M., Hancock L.N., Burcin T.L., Cohn S.M., Ernst P.B., Cominelli F., Meddings J.B., Ley K., and Pizarro T.T. The primary defect in experimental ileitis originates from a nonhematopoietic source. J. Exp. Med. 203 (2006) 541-552
9. Resta-Lenert S., Smitham J., and Barrett K.E. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/-mice. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G153-162
10. Nakamura M., Saito H., Kasanuki J., Tamura Y., and Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 33 (1992) 933-937
11. Niessner M. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101 (1995) 428-435
12. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3 (2003) 521-533
13. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22 (2004) 789-815
14. Ahdieh M., Vandenbos T., and Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. Am. J. Physiol. Cell Physiol. 281 (2001) C2029-2038
15. Kato A., and Schleimer R.P. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19 (2007) 711-720
16. Stolpen A.H., Guinan E.C., Fiers W., and Pober J.S. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am. J. Pathol. 123 (1986) 16-24
17. Madara J.L., and Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83 (1989) 724-727
18. Madara J.L., Barenberg D., and Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol. 102 (1986) 2125-2136
19. Hecht G., Pothoulakis C., LaMont J.T., and Madara J.L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J. Clin. Invest. 82 (1988) 1516-1524
20. Blum M.S., Toninelli E., Anderson J.M., Balda M.S., Zhou J., O'Donnell L., Pardi R., and Bender J.R. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 273 (1997) H286-294
21. Youakim A., and Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 276 (1999) G1279-1288
22. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., and Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171 (2003) 6164-6172
23. Utech M., Bruwer M., and Nusrat A. Tight junctions and cell-cell interactions. Methods Mol. Biol. 341 (2006) 185-195
24. Bruewer M., Utech M., Ivanov A.I., Hopkins A.M., Parkos C.A., and Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 19 (2005) 923-933
25. Utech M., Ivanov A.I., Samarin S.N., Bruewer M., Turner J.R., Mrsny R.J., Parkos C.A., and Nusrat A. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol. Biol. Cell 16 (2005) 5040-5052
26. Minagar A., Long A., Ma T., Jackson T.H., Kelley R.E., Ostanin D.V., Sasaki M., Warren A.C., Jawahar A., Cappell B., and Alexander J.S. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10 (2003) 299-307
27. Feng J., Ito M., Ichikawa K., Isaka N., Nishikawa M., Hartshorne D.J., and Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 274 (1999) 37385-37390
28. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
29. van Deventer S.J. Anti-TNF antibody treatment of Crohn's disease. Ann. Rheum. Dis. 58 Suppl. 1 (1999) I114-120
30. Salva P.S., Doyle N.A., Graham L., Eigen H., and Doerschuk C.M. TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients. Pediatr. Pulmonol. 21 (1996) 11-19
31. Marano C.W., Laughlin K.V., Russo L.M., Peralta Soler A., and Mullin J.M. Long-term effects of tumor necrosis factor on LLC-PK1 transepithelial resistance. J. Cell. Physiol. 157 (1993) 519-527
32. Grant-Tschudy K.S., and Wira C.R. Paracrine mediators of mouse uterine epithelial cell transepithelial resistance in culture. J. Reprod. Immunol. 67 (2005) 1-12
33. Mullin J.M., and Snock K.V. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 50 (1990) 2172-2176
34. Peralta Soler A., Mullin J.M., Knudsen K.A., and Marano C.W. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Physiol. 270 (1996) F869-879
35. Soler A.P., Marano C.W., Bryans M., Miller R.D., Garulacan L.A., Mauldin S.K., Stamato T.D., and Mullin J.M. Activation of NF-kappaB is necessary for the restoration of the barrier function of an epithelium undergoing TNF-alpha-induced apoptosis. Eur. J. Cell Biol. 78 (1999) 56-66
36. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., and Said H.M. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004) G367-376
37. Ma T.Y., Boivin M.A., Ye D., Pedram A., and Said H.M. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G422-430
38. Ye D., Ma I., and Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G496-504
39. McKenzie J.A., and Ridley A.J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J. Cell Physiol. 213 (2007) 221-228
40. Ozaki H., Ishii K., Horiuchi H., Arai H., Kawamoto T., Okawa K., Iwamatsu A., and Kita T. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163 (1999) 553-557
41. Prasad S., Mingrino R., Kaukinen K., Hayes K.L., Powell R.M., MacDonald T.T., and Collins J.E. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Invest. 85 (2005) 1139-1162
42. Zolotarevsky Y., Hecht G., Koutsouris A., Gonzalez D.E., Quan C., Tom J., Mrsny R.J., and Turner J.R. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123 (2002) 163-172
43. Fish S.M., Proujansky R., and Reenstra W.W. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut 45 (1999) 191-198
44. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., and Turner J.R. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166 (2005) 409-419
45. Wong R.K., Baldwin A.L., and Heimark R.L. Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules. Am. J. Physiol. 276 (1999) H736-748
46. Li Q., Zhang Q., Wang M., Zhao S., Ma J., Luo N., Li N., Li Y., Xu G., and Li J. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin. Immunol. 126 (2008) 67-80
47. Schwarz B.T., Wang F., Shen L., Clayburgh D.R., Su L., Wang Y., Fu Y.X., and Turner J.R. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 132 (2007) 2383-2394
48. Graham W.V., Wang F., Clayburgh D.R., Cheng J.X., Yoon B., Wang Y., Lin A., and Turner J.R. Tumor necrosis factor-induced long myosin light chain kinase transcription is regulated by differentiation-dependent signaling events. Characterization of the human long myosin light chain kinase promoter. J. Biol. Chem. 281 (2006) 26205-26215
49. Wang F., Schwarz B.T., Graham W.V., Wang Y., Su L., Clayburgh D.R., Abraham C., and Turner J.R. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131 (2006) 1153-1163
50. Ligumsky M., Simon P.L., Karmeli F., and Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31 (1990) 686-689
51. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., and Wasserman S.I. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89 (1992) 958-967
52. Marcus B.C., Wyble C.W., Hynes K.L., and Gewertz B.L. Cytokine-induced increases in endothelial permeability occur after adhesion molecule expression. Surgery 120 (1996) 411-416 discussion 416-7
53. Al-Sadi R.M., and Ma T.Y. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178 (2007) 4641-4649
54. Duffy H.S., John G.R., Lee S.C., Brosnan C.F., and Spray D.C. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes. J. Neurosci. 20 (2000) RC114
55. Schulzke J.D., Gitter A.H., Mankertz J., Spiegel S., Seidler U., Amasheh S., Saitou M., Tsukita S., and Fromm M. Epithelial transport and barrier function in occludin-deficient mice. Biochim. Biophys. Acta 1669 (2005) 34-42
56. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., Furuse M., Takano H., Noda T., and Tsukita S. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 141 (1998) 397-408
57. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., and Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell. 11 (2000) 4131-4142
58. McCarthy K.M., Skare I.B., Stankewich M.C., Furuse M., Tsukita S., Rogers R.A., Lynch R.D., and Schneeberger E.E. Occludin is a functional component of the tight junction. J. Cell Sci. 109 Pt 9 (1996) 2287-2298
59. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
60. Hanada S., Harada M., Koga H., Kawaguchi T., Taniguchi E., Kumashiro R., Ueno T., Ueno Y., Ishii M., Sakisaka S., and Sata M. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int. 23 (2003) 3-11
61. Colgan S.P., Resnick M.B., Parkos C.A., Delp-Archer C., McGuirk D., Bacarra A.E., Weller P.F., and Madara J.L. IL-4 directly modulates function of a model human intestinal epithelium. J. Immunol. 153 (1994) 2122-2129
62. Wisner D.M., Harris III L.R., Green C.L., and Poritz L.S. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4. J. Surg. Res. 144 (2008) 1-7
63. Furuse M., Furuse K., Sasaki H., and Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153 (2001) 263-272
64. Amasheh S., Meiri N., Gitter A.H., Schoneberg T., Mankertz J., Schulzke J.D., and Fromm M. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J. Cell. Sci. 115 (2002) 4969-4976
65. Van Itallie C.M., Fanning A.S., and Anderson J.M. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am. J. Physiol. Renal. Physiol. 285 (2003) F1078-1084
66. Yang R., Han X., Uchiyama T., Watkins S.K., Yaguchi A., Delude R.L., and Fink M.P. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G621-629
67. Desai T.R., Leeper N.J., Hynes K.L., and Gewertz B.L. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J. Surg. Res. 104 (2002) 118-123
68. Madsen K.L., Lewis S.A., Tavernini M.M., Hibbard J., and Fedorak R.N. Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113 (1997) 151-159
69. Oshima T., Laroux F.S., Coe L.L., Morise Z., Kawachi S., Bauer P., Grisham M.B., Specian R.D., Carter P., Jennings S., Granger D.N., Joh T., and Alexander J.S. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc. Res. 61 (2001) 130-143
70. Mazzon E., Puzzolo D., Caputi A.P., and Cuzzocrea S. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol. Med. 8 (2002) 353-366
71. Heller N.M., Matsukura S., Georas S.N., Boothby M.R., Rothman P.B., Stellato C., and Schleimer R.P. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 31 (2004) 573-582
72. Howe K., Gauldie J., and McKay D.M. TGF-beta effects on epithelial ion transport and barrier: reduced Cl-secretion blocked by a p38 MAPK inhibitor. Am. J. Physiol. Cell Physiol. 283 (2002) C1667-1674
73. Howe K.L., Reardon C., Wang A., Nazli A., and McKay D.M. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am. J. Pathol. 167 (2005) 1587-1597
74. Ozdamar B., Bose R., Barrios-Rodiles M., Wang H.R., Zhang Y., and Wrana J.L. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307 (2005) 1603-1609
75. Gao L., Joberty G., and Macara I.G. Assembly of epithelial tight junctions is negatively regulated by Par6. Curr. Biol. 12 (2002) 221-225
76. Joberty G., Petersen C., Gao L., and Macara I.G. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat. Cell Biol. 2 (2000) 531-539
77. Yamanaka T., Horikoshi Y., Suzuki A., Sugiyama Y., Kitamura K., Maniwa R., Nagai Y., Yamashita A., Hirose T., Ishikawa H., and Ohno S. PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells 6 (2001) 721-731
78. Wang H.R., Zhang Y., Ozdamar B., Ogunjimi A.A., Alexandrova E., Thomsen G.H., and Wrana J.L. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302 (2003) 1775-1779
79. Kojima T., Takano K.I., Yamamoto T., Murata M., Son S., Imamura M., Yamaguchi H., Osanai M., Chiba H., Himi T., and Sawada N. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int. (2007)
80. Nusrat A., Parkos C.A., Bacarra A.E., Godowski P.J., Delp-Archer C., Rosen E.M., and Madara J.L. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J. Clin. Invest. 93 (1994) 2056-2065
81. Date I., Takagi N., Takagi K., Tanonaka K., Funakoshi H., Matsumoto K., Nakamura T., and Takeo S. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci. Lett. 407 (2006) 141-145
82. Palacios F., Schweitzer J.K., Boshans R.L., and D'Souza-Schorey C. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat. Cell Biol. 4 (2002) 929-936
83. Singh A.B., Sugimoto K., Dhawan P., and Harris R.C. Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am. J. Physiol. Cell Physiol. 293 (2007) C1660-1668
84. Harhaj N.S., Barber A.J., and Antonetti D.A. Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells. J. Cell Physiol. 193 (2002) 349-364
85. Fransen L., Ruysschaert M.R., Van der Heyden J., and Fiers W. Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. J. Immunol. 100 (1986) 260-267
86. Adams R.B., Planchon S.M., and Roche J.K. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J. Immunol. 150 (1993) 2356-2363
87. Zeissig S., Burgel N., Gunzel D., Richter J., Mankertz J., Wahnschaffe U., Kroesen A.J., Zeitz M., Fromm M., and Schulzke J.D. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (2007) 61-72
88. Weber C.R., and Turner J.R. Inflammatory bowel disease: is it really just another break in the wall?. Gut 56 (2007) 6-8
89. Laukoetter M.G., Nava P., Lee W.Y., Severson E.A., Capaldo C.T., Babbin B.A., Williams I.R., Koval M., Peatman E., Campbell J.A., Dermody T.S., Nusrat A., and Parkos C.A. JAM-A regulates permeability and inflammation in the intestine in vivo. J. Exp. Med. 204 (2007) 3067-3076
90. Krause G., Winkler L., Mueller S.L., Haseloff R.F., Piontek J., and Blasig I.E. Structure and function of claudins. Biochim. Biophys. Acta 1778 (2007) 631-645
91. Matsuda M., Kubo A., Furuse M., and Tsukita S. A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J. Cell. Sci. 117 (2004) 1247-1257
92. Van Itallie C.M., Holmes J., Bridges A., Gookin J.L., Coccaro M.R., Proctor W., Colegio O.R., and Anderson J.M. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J. Cell. Sci. 121 (2008) 298-305
93. Farshori P., and Kachar B. Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells. J. Membr. Biol. 170 (1999) 147-156
94. Fujibe M., Chiba H., Kojima T., Soma T., Wada T., Yamashita T., and Sawada N. Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp. Cell Res. 295 (2004) 36-47
95. Van Itallie C.M., Colegio O.R., and Anderson J.M. The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. J. Membr. Biol. 199 (2004) 29-38
96. Tanaka M., Kamata R., and Sakai R. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. J. Biol. Chem. 280 (2005) 42375-42382
97. D'Souza T., Agarwal R., and Morin P.J. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J. Biol. Chem. 280 (2005) 26233-26240
98. Cohen N.A., Brenman J.E., Snyder S.H., and Bredt D.S. Binding of the inward rectifier K+channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation. Neuron 17 (1996) 759-767
99. Schmitz H., Fromm M., Bentzel C.J., Scholz P., Detjen K., Mankertz J., Bode H., Epple H.J., Riecken E.O., and Schulzke J.D. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell. Sci. 112 Pt. 1 (1999) 137-146
100. Shiou S.R., Singh A.B., Moorthy K., Datta P.K., Washington M.K., Beauchamp R.D., and Dhawan P. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res. 67 (2007) 1571-1579
101. Alexander J.S., Jackson S.A., Chaney E., Kevil C.G., and Haselton F.R. The role of cadherin endocytosis in endothelial barrier regulation: involvement of protein kinase C and actin-cadherin interactions. Inflammation 22 (1998) 419-433
102. Ivanov A.I., Nusrat A., and Parkos C.A. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 27 (2005) 356-365
103. Ivanov A.I., McCall I.C., Parkos C.A., and Nusrat A. Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol. Biol. Cell 15 (2004) 2639-2651
104. Stevenson B.R., and Begg D.A. Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells. J. Cell. Sci. 107 Pt. 3 (1994) 367-375
105. Ma T.Y., Hoa N.T., Tran D.D., Bui V., Pedram A., Mills S., and Merryfield M. Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G875-885
106. Yuhan R., Koutsouris A., Savkovic S.D., and Hecht G. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology 113 (1997) 1873-1882
107. Goldblum S.E., Ding X., and Campbell-Washington J. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am. J. Physiol. 264 (1993) C894-905
108. Marano C.W., Lewis S.A., Garulacan L.A., Soler A.P., and Mullin J.M. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J. Membr. Biol. 161 (1998) 263-274